Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSENTAN\BOSENTAN for Pulmonary arterial hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 2,673 adverse event reports in the FDA FAERS database where BOSENTAN\BOSENTAN was used for Pulmonary arterial hypertension.

Most Reported Side Effects for BOSENTAN\BOSENTAN

Side Effect Reports % Deaths Hosp.
Death 543 15.6% 542 118
Dyspnoea 443 12.7% 104 384
Pulmonary arterial hypertension 245 7.0% 149 143
Pneumonia 220 6.3% 62 202
Fall 182 5.2% 22 160
Condition aggravated 161 4.6% 84 95
Fluid retention 125 3.6% 30 117
Syncope 115 3.3% 17 97
Nausea 113 3.2% 20 95
Fatigue 111 3.2% 15 87
Dizziness 106 3.0% 11 90
Disease progression 99 2.8% 84 49
Malaise 98 2.8% 22 82
Cardiac failure congestive 97 2.8% 37 77
Cough 97 2.8% 10 74

Other Indications for BOSENTAN\BOSENTAN

Cor pulmonale chronic (238) Pulmonary hypertension (238) Product used for unknown indication (187) Scleroderma associated digital ulcer (38) Systemic sclerosis (16) Skin ulcer (15) Portopulmonary hypertension (10) Raynaud's phenomenon (8) Heart disease congenital (7) Scleroderma (6)

Other Drugs Used for Pulmonary arterial hypertension

TREPROSTINIL (72,609) MACITENTAN (29,246) AMBRISENTAN (27,852) BOSENTAN (12,387) SELEXIPAG (11,861) RIOCIGUAT (9,158) EPOPROSTENOL (8,508) TADALAFIL (7,679) SILDENAFIL (5,239) ILOPROST (2,828)

Related Pages

BOSENTAN\BOSENTAN Full Profile All Pulmonary arterial hypertension Drugs BOSENTAN\BOSENTAN Demographics BOSENTAN\BOSENTAN Timeline